Suchergebnisse - "Deftereos, Spyridon G"

PubPharm (29)

1

Left Distal Radial Artery Access for Coronary Angiography and Interventions : A 12-Month All-Comers Study

enthalten in: The Journal of invasive cardiology | 2022

von Bompotis, G. | Giannopoulos, G. | Karakanas, A. | +7

2

2021 ESC guidelines on cardiac pacing and cardiac resynchronization : what is the correct level of evidence for the superiority of cephalic vein cutdown? C, B or maybe A?

enthalten in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology | 2022

von Iliodromitis, K. | Deftereos, S. | Bogossian, H.

CommentIn: Europace. 2022 Apr 5;24(4):697. - PMID 35061881

3

Colchicine in Cardiovascular Disease : In-Depth Review

enthalten in: Circulation | 2022

von Deftereos, S. | Beerkens, F. | Shah, B. | +11

4

Impact of colchicine on mortality in patients with COVID-19 : A meta-analysis

enthalten in: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese | 2021

von Vrachatis, D. | Giannopoulos, G. | Giotaki, S. | +9

5

Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics : A Narrative Review

enthalten in: Diagnostics (Basel, Switzerland) | 2021

von Papathanasiou, K. | Giotaki, S. | Vrachatis, D. | +11

6

Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations

enthalten in: Drugs | 2021

von Vrachatis, D. | Papathanasiou, K. | Iliodromitis, K. | +12

7

Colchicine for community-treated patients with COVID-19 (COLCORONA) : a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Tardif, J. | Bouabdallaoui, N. | L'Allier, P. | +42

CommentIn: Lancet Respir Med. 2021 Aug;9(8):811-812. - PMID 34051878

8

Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations

enthalten in: Drugs | 2021

von Vrachatis, D. | Papathanasiou, K. | Iliodromitis, K. | +12

9

Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations

enthalten in: Drugs | 2021

von Vrachatis, D. | Papathanasiou, K. | Iliodromitis, K. | +12

10

Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations

enthalten in: Drugs | 2021

von Vrachatis, D. | Papathanasiou, K. | Iliodromitis, K. | +12